Results

Total Results: 475 records

Showing results for "gender".

41. Cer-235-Pharma-Nonpharm-Ptsd-Update-Appendix-G-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
    May 29, 2025 - non-opaque envelopes Unclear: • No details Yes: • Key baseline characteristics: demographics (age, gender … difference exceeds MCID for instrument • ≥20% differential on demographics Unclear: • No details on age, gender

42. Misuse of Prescription Stimulants in Adults (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol-amendment.pdf
    November 26, 2024 - Date Section Original Protocol Revised Protocol Rationale 2/6/2025 Key Questions, Methods “Gender … “Gender” removed or replaced with “sex”. … The language was updated to comply with Executive Order 14168, “Defending Women From Gender Ideology

43. Cervical Degenerative Disease Treatment (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cervical-degenerative-protocol.pdf
    January 12, 2022 - pseudarthrosis after cervical fusion surgery);18 (5) utility of patient characteristics (e.g., age, gender … assess how effectiveness and harms may differ by patient and disease characteristics (e.g., age, gender … on patient characteristics, disease characteristics and radiographic characteristics (e.g., age, gender … are likely to impact applicability include characteristics of enrolled patient populations (e.g., gender … Prevalence of spine degeneration diagnosis by type, age, gender, and obesity using Medicare data.

44. Updating the Measurement Criteria for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-criteria-qdr-protocol-amendment.pdf
    December 28, 2023 - https://www.cdc.gov/healthyyouth/disparities/index.htm Version 5 4/18/2019 7 2/7/2025 Methods “Gender … “Gender” replaced with “sex”. … The language was updated to comply with Executive Order 14168, “Defending Women From Gender Ideology

45. Renal-Function Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
    June 13, 2013 - There is no consensus on how to define a reference population for the assays (in terms of age, gender … Gender b. Age c. Ethnicity d. … Gender b. Age c. Ethnicity d. … Gender b. Age c. Ethnicity d. … Gender b. Age c. Ethnicity d.

46. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0210_12-07-2009.pdf
    January 01, 2009 - effectiveness or harms of these treatments for specific subpopulations (e.g., severity of TBI, race, gender

47. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0068_01-30-2009.pdf
    January 01, 2009 -  Gender  Children with signs/symptoms of synovitis versus children with vague musculoskeletal complaints

48. Chronic-Urinary-Retention Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
    September 01, 2014 - Intervention: transurethral resection of the prostate (TURP) n=17 Age, mean: 67 Gender: men 100% … Exclusion criteria: NR N=21 Intervention: botulinum A toxin n=11 Age, mean: 67 Gender: men … Intervention: bethanechol chloride (BC) plus prostaglandin E2 (PGE2) n=9 Age, mean: 67 Gender: … Comorbidities: Spinal cord injury: 80% MS: 20% Control: lidocaine n=8 Age, mean: 49 Gender: … Intervention: Transurethral prostatic resection n=44 Age, mean:71 Gender: men 100% Race: white

49. Disposition of Comments_Comparative Effectiveness Review No. 256: Effectiveness of Telehealth for Women's Preventive Services (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-256-telehealth-women-disposition-comments.pdf
    June 16, 2022 - I like the approach of being inclusive and saying that the term applies to individuals of all gender … who identified as having non-male partners, but no other studies were specifically conducted in gender … as to whether the study samples were inclusive or if any conclusions could be drawn across various gender … I suspect that no studies reported on transgender, gender non- binary, or other gender identities. … who identified as having non-male partners, but no other studies were specifically conducted in gender

50. Diabetes-Foot-Ulcer-Amputation-Economics Research (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-economics_research.pdf
    January 01, 2011 - 1.2 47.1 7.8 95 and over 2006 25.3 0.9 33.5 5.8 2007 27.2 0.9 36.6 6.3 2008 28.5 0.9 39.7 7.3 Gender … These rates did not vary widely by gender or race/eth- nicity, but did vary by age. … These rates did not vary widely by age, gender, or race/ethnicity. … Gender, race/ethnicity, and age were all extracted from the EDB.

51. Epilepsy-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - Gender, genetic profile, and polypharmacy’s impact on results could not be determined. … No controlled clinical trials and one controlled observational study reported data on gender, age, … AEDs versus 23.6% (zonisamide) to 44.8% (gabapentin) Herzog, 201113 Prospective cohort study Gender … Gender, genetic profile, and polypharmacy’s impact on results could not be determined. … No controlled clinical trials and one controlled observational study reported data on gender, age,

52. Epilepsy-Medicine Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - Gender, genetic profile, and polypharmacy’s impact on results could not be determined. … No controlled clinical trials and one controlled observational study reported data on gender, age, … AEDs versus 23.6% (zonisamide) to 44.8% (gabapentin) Herzog, 201113 Prospective cohort study Gender … Gender, genetic profile, and polypharmacy’s impact on results could not be determined. … No controlled clinical trials and one controlled observational study reported data on gender, age,

53. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cystic-fibrosis-hgh_research-protocol.pdf
    August 22, 2008 - also called standard deviation scores or SDS) provide a relationship with the mean based on age and gender … characteristics of interest include, but are not limited to: age (pre-pubertal, pubertal, post-pubertal); gender … In patients with cystic fibrosis and relevant subgroups based upon gender, age, baseline clinical status … Subgroup analyses will be conducted to assess the effect age, gender, and baseline clinical status on … Subgroup analyses will be conducted to assess the effect age, gender, and baseline clinic...

54. Methods Research Report: Developing Consistent and Useful Quality Improvement Study Data Extraction (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/developing-consistent-useful-quality-improvement.pdf
    September 01, 2020 - No info on age, gender, ethnicity, language, or training of providers No info on age, gender, ethnicity … providers No info on age, gender, ethnicity, language or training for both. … No info on age, gender, ethnicity, language, or training of providers No info on age, gender, ethnicity … No info on age, gender, ethnicity, language, or training of multidisciplinary team. … No info on age, gender, language, or training of recipients.

55. Siminoff_ECCS2012 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/siminoff_eccs2012.pdf
    January 01, 2012 - individual’s relationships  with  others  and  with   the environment  Socioeconomic status  Gender … Their Primary Caregivers Patient Caregiver Var i ab le N (%) N (%) Age (mean ± SD) 65 ± 10 55 ± 14 Gender

56. Disposition of Comments_Systematic Review: Breastfeeding and Health Outcomes for Infants and Children (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-disposition-comments.pdf
    March 31, 2025 - identity, and focus on observational studies. … However, we urge the continued inclusion and centering of gender-inclusive language in future updates … The gender-inclusive language in our report has been edited to comply with Executive Orders issued … The gender-inclusive language in our report has been edited to comply with Executive Orders issued … The gender-inclusive language in our report has been edited to comply with Executive Orders issued

57. Future Research Needs for Diagnosis of Obstructive Sleep Apnea (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
    February 01, 2012 - Age and gender specific criteria for abnormal breathing (or OSA) 2. … Age- and gender-specific criteria for defining the OSA syndrome (and abnormal breathing) 2. … Age- and gender-specific criteria for defining the OSA syndrome (and abnormal breathing) 2. … None of these studies used age- or gender-specific criteria. … Proposed Research Design The aim of this topic is to identify age- and gender-specific criteria for

58. Enhanced Functionality for the Distributed Research Network Pilot (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-expansion_research.pdf
    April 01, 2012 - Query parameter selection will be expanded to include filtering by age group and gender. … Gender List of Genders available for selection Age Groups List of Age range available for selection … Gender List of genders(‘M’, ‘F’) available for selection Age Groups List of age range available for … Gender Both choices should be selected by default. … If both choices are selected, then no filtering by gender is needed.

59. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
    May 19, 2010 - unclear due to insufficient information in the previous study: subpopulation (i.e., race / ethnicity, gender … Do efficacy, effectiveness, and harms differ by race/ethnicity, gender, and age group? … Benefits and harms for specific subpopulations (by gender, age, and race/ethnicity) or related to other

60. Treatments for Acute Pain: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-protocol-acute-pain-treatments.pdf
    August 08, 2019 - effectiveness of opioid therapy vary depending on: (1) patient demographics (e.g. age, race, ethnicity, gender … How do harms vary depending on: (1) patient demographics (e.g., age, gender); (2) patient medical or … nonopioid pharmacologic therapy vary depending on: (1) patient demographics (e.g. age, race, ethnicity, gender … does effectiveness of nonpharmacologic therapy vary depending on: (1) patient demographics (e.g. age, gender … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical and